Medicine recalls in Saudi Arabia: a retrospective review of drug alerts (January 2010–January 2019)
Abstract Background A new incidence of a substandard medicinal product is discovered weekly as stated by the World Health Organization (WHO) around the world. After discovering an incidence of a substandard medicinal product, a drug recall announced to remove the affected medicinal product from the...
Main Authors: | Bushra T. AlQuadeib, Iman M. Alfagih, Ameera H. Alnahdi, Shadia M. Alharbi, Rawan A. Al-ahmari |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-11-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43094-020-00112-3 |
Similar Items
-
Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01) -
Global scenario of counterfeit antimalarials: A potential threat
by: Taruna Arora, et al.
Published: (2019-01-01) -
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01) -
Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
by: Sachiko Ozawa, et al.
Published: (2019-01-01)